Pluristem Therapeutics (PSTI) to Deliver Two Presentations During Israel's Largest Biotech Conference: IATI-BioMed
6/10/2013 9:41:16 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HAIFA, Israel, June 10, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Pluristem's CEO and its Project Innovation Research Manager will be delivering two different presentations during Israel's largest biotechnology conference, the 12th Annual IATI-BioMed Conference June 10th through 12th, 2013 in Tel Aviv.
Help employers find you! Check out all the jobs and post your resume.
comments powered by